PIN63 - Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece
| Autor: | Mylonas, C, Kourlaba, G, Vernadaki, A, Kakouros, M, Maniadakis, N |
|---|---|
| Zdroj: | In Value in Health November 2016 19(7):A418-A418 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect